NCT05306340 · Interventional trial
A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With the Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer)
Overall registry status Active not recruiting
Phase 3
Conditions Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast Cancer
Delaware Valley sites
- Abramson Cancer Center · Philadelphia, PA · Philadelphia County
- Abramson Cancer Center Chester County Hospital · West Chester, PA · Chester County
First posted
Registry updated
Added to the directory